Patents by Inventor James N. MacLeod

James N. MacLeod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7067477
    Abstract: One aspect of the present invention is an isolated nucleic acid molecule encoding canine erythropoietin. The present invention also relates to an isolated canine erythropoietin protein or polypeptide. Another aspect of the present invention is a method for providing erythropoietin therapy to a dog or a cat including administering recombinant canine erythropoietin to a dog or a cat in need of erythropoietin therapy in an amount sufficient to increase production of reticulocytes and red blood cells in the dog or cat.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: June 27, 2006
    Assignee: Cornell Research Foundation, Inc.
    Inventor: James N. MacLeod
  • Publication number: 20040138129
    Abstract: One aspect of the present invention is an isolated nucleic acid molecule encoding canine erythropoietin. The present invention also relates to an isolated canine erythropoietin protein or polypeptide. Another aspect of the present invention is a method for providing erythropoietin therapy to a dog or a cat including administering recombinant canine erythropoietin to a dog or a cat in need of erythropoietin therapy in an amount sufficient to increase production of reticulocytes and red blood cells in the dog or cat.
    Type: Application
    Filed: January 9, 2004
    Publication date: July 15, 2004
    Inventor: James N. MacLeod
  • Patent number: 6696411
    Abstract: One aspect of the present invention is an isolated nucleic acid molecule encoding canine erythropoietin. The present invention also relates to an isolated canine erythropoietin protein or polypeptide. Another aspect of the present invention is a method for providing erythropoietin therapy to a dog or a cat including administering recombinant canine erythropoietin to a dog or a cat in need of erythropoietin therapy in an amount sufficient to increase production or reticulocytes and red blood cells in the dog or cat.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: February 24, 2004
    Assignee: Cornell Research Foundation, Inc.
    Inventor: James N. MacLeod
  • Patent number: 4900313
    Abstract: A novel swivel tethering system for attaching to a cage of a laboratory animal is disclosed which provides a greater degree of mobility for laboratory animals. This tethering system provides for extended lateral movement which is not limited to the tether length and is ideally suited for chronic indwelling catheterization since it can minimize the stress created in the animals caused by a limited tether length, thereby reducing the potential distortion of blood parameters.
    Type: Grant
    Filed: April 28, 1988
    Date of Patent: February 13, 1990
    Assignee: Trustees of the University of Pennsylvania
    Inventors: James N. MacLeod, Bernard H. Shapiro
  • Patent number: 4756707
    Abstract: A novel swivel tethering system for attaching to a cage of a laboratory animal is disclosed which provides a greater degree of mobility for laboratory animals. This tethering system provides for extended lateral movement which is not limited to the tether length and is ideally suited for chronic indwelling catheterization since it can minimize the stress created in the animals caused by a limited tether length, thereby reducing the potential distortion of blood parameters.
    Type: Grant
    Filed: July 6, 1987
    Date of Patent: July 12, 1988
    Assignee: Trustees of the University of Pennsylvania
    Inventors: James N. MacLeod, Shapiro, Bernard H.
  • Patent number: RE40911
    Abstract: One aspect of the present invention is an isolated nucleic acid molecule encoding canine erythropoietin. The present invention also relates to an isolated canine erythropoietin protein or polypeptide. Another aspect of the present invention is a method for providing erythropoietin therapy to a dog or a cat including administering recombinant canine erythropoietin to a dog or a cat in need of erythropoietin therapy is an amount sufficient to increase production or reticulocytes and red blood cells in the dog or cat.
    Type: Grant
    Filed: April 21, 1999
    Date of Patent: September 8, 2009
    Assignee: Cornell Research Foundation, Inc.
    Inventor: James N. MacLeod